TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SNTI

Senti Biosciences Inc

Healthcare · Biotechnology

0.32$ +2.2% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Senti Biosciences Inc (SNTI): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/06/2026.

Next report 08/06/2026
Last report 08/14/2026
Earnings surprise by quarter (%)
Q3 23 · 42.5 % 23 Q4 23 · -82.2 % 23 Q4 24 · 78.6 % 24 Q1 25 · -151.8 % 25 Q2 25 · -1.8 % 25 Q3 25 · -21.1 % 25 Q4 25 · -12.0 % 25 Q1 26 · 61.1 % 26 Q2 26 · -24.2 % 26

EPS estimate beaten

Full history 6 of 13 quarters (46%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/04/2026 Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/02/2026 Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗
  • 08/20/2026 Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant · sec.gov Open ↗
  • 07/15/2026 Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Results of Operations and Financial Condition; Changes in Control of Registrant; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?